Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Polonsky, K.
Right arrow Articles by Rubenstein, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Polonsky, K.
Right arrow Articles by Rubenstein, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 35, Issue 4 379-386, Copyright © 1986 by American Diabetes Association


ARTICLES

The limitations to and valid use of C-peptide as a marker of the secretion of insulin

K Polonsky, B Frank, W Pugh, A Addis, T Karrison, P Meier, H Tager and A Rubenstein

The accuracy with which the secretion rate of insulin can be calculated from peripheral concentrations of C-peptide was investigated in conscious mongrel dogs. Biosynthetic human C-peptide and insulin were infused intraportally and their concentrations measured in the femoral artery. During steady-state infusions of C-peptide, the peripheral concentration changed in proportion to the infusion rate and the metabolic clearance rate (5.2 +/- 0.3 ml/kg/min) remained constant over a wide range of plasma concentrations. Application of a two-compartment mathematical model, in which the model parameters were estimated from analysis of C-peptide decay curves after intravenous bolus injections, allowed the intraportal infusion rate of C-peptide to be derived from peripheral C-peptide concentrations, even under non-steady-state conditions. Estimates of the intraportal infusion rate based on this model were 102.4 +/- 2.6% of the actual infusion rate as it was increasing and 102.3 +/- 5.5% of this rate as it was falling. The peripheral C-peptide: insulin molar ratio was influenced by the rate at which equimolar intraportal infusions of C-peptide and insulin were changed. The baseline C-peptide: insulin molar ratio (4.1 +/- 0.9) increased to peak values of 8.2 +/- 0.6, 10.3 +/- 2.0, and 14.9 +/- 1.3 when the infusion rate was increased and then decreased rapidly. Peak values of only 5.7 +/- 1.2 were found if the intraportal infusion rate was changed slowly.(ABSTRACT TRUNCATED AT 250 WORDS)
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
N. A. Sherry, E. B. Tsai, and K. C. Herold
Natural History of {beta}-Cell Function in Type 1 Diabetes
Diabetes, December 1, 2005; 54(suppl_2): S32 - S39.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. N. Rudovich, H. J. Rochlitz, and A. F.H. Pfeiffer
Reduced Hepatic Insulin Extraction in Response to Gastric Inhibitory Polypeptide Compensates for Reduced Insulin Secretion in Normal-Weight and Normal Glucose Tolerant First-Degree Relatives of Type 2 Diabetic Patients
Diabetes, September 1, 2004; 53(9): 2359 - 2365.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Steele, W. A. Hagopian, S. Gitelman, U. Masharani, M. Cavaghan, K. I. Rother, D. Donaldson, D. M. Harlan, J. Bluestone, and K. C. Herold
Insulin Secretion in Type 1 Diabetes
Diabetes, February 1, 2004; 53(2): 426 - 433.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Vilsboll, T. Krarup, J. Sonne, S. Madsbad, A. Volund, A. G. Juul, and J. J. Holst
Incretin Secretion in Relation to Meal Size and Body Weight in Healthy Subjects and People with Type 1 and Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2706 - 2713.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Aarnio, T. Lauritsen, and F. Dela
Insulin Secretion and Glucose Kinetics During Exercise With and Without Pharmacological {alpha}1- and {alpha}2-Receptor Blockade
Diabetes, August 1, 2001; 50(8): 1834 - 1843.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
X. Guan, J. J. Matte, P. K. Ku, J. L. Snow, J. L. Burton, and N. L. Trottier
High Chromium Yeast Supplementation Improves Glucose Tolerance in Pigs by Decreasing Hepatic Extraction of Insulin
J. Nutr., May 1, 2000; 130(5): 1274 - 1279.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. K. Krishnan, J. M. Hernandez, D. L. Williamson, D. J. O'Gorman, W. J. Evans, and J. P. Kirwan
Age-related differences in the pancreatic beta -cell response to hyperglycemia after eccentric exercise
Am J Physiol Endocrinol Metab, September 1, 1998; 275(3): E463 - E470.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. Christiansen, L. L. Kjems, A. Volund, A. Tibell, C. Binder, and S. Madsbad
Insulin secretion rates estimated by two mathematical methods in pancreas-kidney transplant recipients
Am J Physiol Endocrinol Metab, April 1, 1998; 274(4): E716 - E725.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. M. Watanabe, G. M. Steil, and R. N. Bergman
Critical evaluation of the combined model approach for estimation of prehepatic insulin secretion
Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E172 - E183.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1986 by the American Diabetes Association.